Research Interests
Dr. Claus Storgaard Sørensen is an Associate Professor at the Biotech Research & Innovation Centre (BRIC), University of Copenhagen, where he leads research on genome stability and DNA damage repair mechanisms, particularly in the context of cancer and neurological diseases. His work combines cutting-edge tools such as CRISPR-based genome editing, replication fork protection assays, and high-throughput genetic screening to understand the molecular basis of disease and identify therapeutic targets. He has an impressive record of international collaborations and has published in top-tier journals including Nature Communications, Cell Reports, and JCI. Dr. Sørensen also contributes to translational research through his leadership roles in biotech companies like Oncostress Therapeutics IVS and BioPhenyx ApS. His commitment to both scientific innovation and collaboration underscores his impact in advancing precision medicine and cancer research.
Keywords
Genome Stability, DNA Damage Repair, CRISPR-based Screening, Cancer Therapeutics, Translational Research